Global Longlife Hospital and Research Ltd IPO

Incorporated in 1983, Kolkata-based Tarsons Products manufactures laboratory products that are used in various research organisations, pharmaceutical companies, academia institutes, hospitals and diagnostic centres.

The company plans to go public and here’s all you need to know about this IPO.

Here’s the consolidated financial information for the last three years:

• Ultra-Modern Medicinal Practices
• Prime Location of its Hospital
• Team of Medical Practitioners
• Clinical excellence and affordable health care
• Grow its presence in adjacent Markets.

• Discontinuation of association by doctors and other healthcare professionals with its hospitals for any reason, and its inability to retain them may adversely affect its business and results of operations.
• If the company is unable to keep abreast with technological changes, new equipment and service introductions, changes in patients' needs and evolving industry standards, its business and financial condition may be adversely affected. Further, its will also incur costs associated with replacing obsolete equipment.
• The Industry in highly regulated industry requires compliances of various laws and regulations as the human life is involved.
• The company's business requires its to obtain a number of approvals, NOCs, licenses, registrations and permits and renew certain registrations, licenses and permits from government and regulatory authorities as well. Failure to obtain them or renewal of them in a timely manner may adversely affect its business operations.
• The Company has given short term loans/advances to Directors, which is not in compliance with the provisions of Section 185/295 of the Companies Act, 2013/1956.

• Ultra-Modern Medicinal Practices
• Prime Location of its Hospital
• Team of Medical Practitioners
• Clinical excellence and affordable health care
• Grow its presence in adjacent Markets.